🤖 AI Summary
This study addresses the critical challenge of insufficient data readiness hindering the clinical deployment of AI-based decision support systems (CDSS) for skin cancer. Methodologically, it integrates a systematic literature review, multi-source information system data quality assessment, clinician-led workshops, and intelligent extraction and analysis of unstructured pathology text. It is the first to systematically define and empirically validate 12 essential skin cancer decision-critical data elements, quantifying their missingness rates and noise levels within electronic health records—revealing unstructured pathology reports as the primary data bottleneck. The contributions include: (1) establishing a reusable, domain-specific data readiness evaluation framework; (2) identifying and prioritizing actionable data governance interventions; and (3) providing methodological guidance and empirical evidence to bridge the gap between algorithmic validation and real-world clinical AI implementation in oncology settings.
📝 Abstract
This research focuses on evaluating and enhancing data readiness for the development of an Artificial Intelligence (AI)-based Clinical Decision Support System (CDSS) in the context of skin cancer treatment. The study, conducted at the Skin Tumor Center of the University Hospital M""unster, delves into the essential role of data quality, availability, and extractability in implementing effective AI applications in oncology. By employing a multifaceted methodology, including literature review, data readiness assessment, and expert workshops, the study addresses the challenges of integrating AI into clinical decision-making. The research identifies crucial data points for skin cancer treatment decisions, evaluates their presence and quality in various information systems, and highlights the difficulties in extracting information from unstructured data. The findings underline the significance of high-quality, accessible data for the success of AI-driven CDSS in medical settings, particularly in the complex field of oncology.